Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

MicroMedicine

MicroMedicine?uq=kzBhZRuG
2015 FOUNDED
PRIVATE STATUS
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of cell separation technology intended to isolate contaminated cells. The company's technology makes use of a cell isolator device which selectively separates target cells from blood and bone marrow thus separating contaminated cells like red blood cells and platelets for use in infection imaging and tissue regeneration.

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Discovery Tools (Healthcare)
Primary Office
  • 313 Pleasant Street
  • Watertown, MA 02472
  • United States

+1 (617) 000-0000

MicroMedicine Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore MicroMedicine‘s full profile, request access.

Request full access to PitchBook

MicroMedicine Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore MicroMedicine‘s full profile, request access.

Request full access to PitchBook

MicroMedicine Executive Team (2)

Name Title Board
Seat
Contact
Info
Ravi Kapur Ph.D Co-Founder, President & Board Member
Ronald Tompkins MD Co-Founder

MicroMedicine Board Members (5)

Name Representing Role Since Contact
Info
0000 000000 OYAK Board Member 000 0000
00000 00000 OYAK Board Member 000 0000
00000 00000 OYAK Chairman 000 0000
000000 00000 00.0 MicroMedicine Co-Founder & Board Member 000 0000
0000 00000 00.0 MicroMedicine Co-Founder, President & Board Member 000 0000